enVVeno Medical (NVNO) FCF Margin (2017 - 2019)

enVVeno Medical's FCF Margin history runs 3 years deep, the most recent figure standing at 4786.21% for Q1 2019.

• On a quarterly basis, FCF Margin rose 44611.0% year-over-year to 4786.21% in Q1 2019; TTM through Dec 2019 was 20037.42%, a 1662821.0% decrease from a year earlier, with the FY2019 full-year figure at 20037.42%, down 1662375.0% from the prior year.
• FCF Margin retreated to 4786.21% in Q1 2019 per NVNO's latest filing, from 4756.1% in the prior quarter.
• Across five years, FCF Margin topped out at 730.85% in Q4 2017 and bottomed at 5232.32% in Q1 2018.
• The 3-year median for FCF Margin is 4337.59% (2017), against an average of 3697.05%.
• Across the five-year window, FCF Margin tumbled 402525 bps in 2018 and jumped 44611 bps in 2019, its largest moves.
• Year by year, FCF Margin stood at 730.85% in 2017, then plunged by 551 bps to 4756.1% in 2018, then dropped by 1 bps to 4786.21% in 2019.
• Per Business Quant, the three latest NVNO FCF Margin figures stand at 4786.21% (Q1 2019), 4756.1% (Q4 2018), and 4187.65% (Q3 2018).